DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 180 filers reported holding DIPLOMAT PHARMACY INC in Q3 2018. The put-call ratio across all filers is 2.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $472,000 | -23.0% | 118,085 | -5.6% | 0.00% | – |
| Q3 2019 | $613,000 | +12.7% | 125,086 | +40.0% | 0.00% | – |
| Q2 2019 | $544,000 | -39.6% | 89,349 | -42.4% | 0.00% | – |
| Q1 2019 | $901,000 | -31.6% | 155,201 | +58.6% | 0.00% | – |
| Q4 2018 | $1,317,000 | -29.0% | 97,858 | +2.3% | 0.00% | -100.0% |
| Q3 2018 | $1,856,000 | -18.1% | 95,621 | +7.8% | 0.00% | 0.0% |
| Q2 2018 | $2,267,000 | +41.2% | 88,723 | +11.4% | 0.00% | – |
| Q1 2018 | $1,605,000 | -11.3% | 79,659 | -11.6% | 0.00% | -100.0% |
| Q4 2017 | $1,809,000 | +22.4% | 90,104 | +26.3% | 0.00% | – |
| Q3 2017 | $1,478,000 | +91.9% | 71,361 | +37.3% | 0.00% | – |
| Q2 2017 | $770,000 | -26.0% | 51,988 | -20.4% | 0.00% | – |
| Q1 2017 | $1,041,000 | -7.3% | 65,284 | -26.7% | 0.00% | – |
| Q4 2016 | $1,123,000 | -98.4% | 89,073 | -96.4% | 0.00% | -100.0% |
| Q3 2016 | $69,843,000 | -18.2% | 2,493,518 | +2.2% | 0.03% | -21.2% |
| Q2 2016 | $85,368,000 | +20.5% | 2,439,105 | -5.7% | 0.03% | +17.9% |
| Q1 2016 | $70,854,000 | +16.4% | 2,585,926 | +45.3% | 0.03% | +16.7% |
| Q4 2015 | $60,896,000 | +342.9% | 1,779,549 | +271.9% | 0.02% | +300.0% |
| Q3 2015 | $13,749,000 | -41.2% | 478,524 | -8.4% | 0.01% | -33.3% |
| Q2 2015 | $23,372,000 | -28.3% | 522,273 | -44.6% | 0.01% | +50.0% |
| Q1 2015 | $32,608,000 | +360.4% | 942,974 | +264.4% | 0.01% | +100.0% |
| Q4 2014 | $7,083,000 | – | 258,774 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|